In animal models of stroke and pulmonary embolism, tPA–DNA nanodevices demonstrated superior thrombolytic efficacy, prolonged circulation time, and reduced bleeding compared to free tPA [67]. This evidence concerns the gene PLAT and pulmonary embolism.